Dirk Schepmann

Publishing 2014–2019

Is this you? Claim this profile
3
Articles
1,036
Reads on Journament
18
Co-authors
3
Journals

This page collects the articles indexed under the name Dirk Schepmann. Profiles are grouped by name, so it can include work by someone else who shares it until the author claims the profile and confirms which papers are theirs.

Publications 3

  1. Discovery of new potent dual sigma receptor/GluN2b ligands with antioxidant property as neuroprotective agents.
    Daniele Zampieri, Sara Fortuna, Antonella Calabretti, Maurizio Romano, Renzo Menegazzi, Dirk Schepmann, Bernhard Wünsch, Simona Collina, Davide Zanon, Maria Grazia Mamolo
    European journal of medicinal chemistry 2019 303 reads
  2. Modification of the 4-phenylbutyl side chain of potent 3-benzazepine-based GluN2B receptor antagonists.
    Marina Wagner, Dirk Schepmann, Simon M Ametamey, Bernhard Wünsch
    bioorganic & medicinal chemistry 2019 288 reads
  3. Asymmetric Synthesis of Spirocyclic 2-Benzopyrans for Positron Emission Tomography of σ1 Receptors in the Brain.
    Katharina Holl, Dirk Schepmann, Steffen Fischer, Friedrich-Alexander Ludwig, Achim Hiller, Cornelius K Donat, Winnie Deuther-Conrad, Peter Brust, Bernhard Wünsch
    Pharmaceuticals (Basel, Switzerland) 2014 445 reads University of Münster

Is this you?

Claim this profile to connect it to your account. You will be able to remove papers that are not yours, fold in other spellings of your name, and show your affiliation and photo here.

An admin reviews every claim. Your account's name, email address and affiliation are shown to them too.

You need an account to claim. No password: we email you a sign-in link, and your claim is sent as soon as you are back.

Institutions on these papers

  • University of Münster · DE 1

From OpenAlex, for papers with a DOI.

Frequent co-authors

Publishes in